Posted on 1326
Veristat, a scientific-minded global clinical research organization (CRO), announced today the launch of business operations in Spain and the appointment of Montserrat (Montse) Barceló Riera, M.D. as Vice President, Europe. Montse supported the launch of the new Veristat affiliate and is located in Barcelona, Spain. Barcelona is a city known to be one of the fastest growing biotechnology hubs for oncology clinical trials.
Dr. Montse Barcelo, Vice President, Europe, Veristat (Photo: Business Wire)
In this role, Dr. Barceló will focus her energy and experience on leading Veristat’s growing European client base and functional capabilities, concentrating on high impact client engagements with the highest quality personnel in the industry.